Aortic Pulse Wave Velocity Is Associated With Measures of Subclinical Target Organ Damage  by Coutinho, Thais et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 4 , N O . 7 , 2 0 1 1
© 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 1 . 0 4 . 0 1 1Aortic Pulse Wave Velocity Is Associated With
Measures of Subclinical Target Organ Damage
Thais Coutinho, MD,*† Stephen T. Turner, MD,*‡ Iftikhar J. Kullo, MD*†
Rochester, Minnesota
O B J E C T I V E S Our goal was to evaluate the associations of central arterial stiffness, measured by
aortic pulse wave velocity (aPWV), with subclinical target organ damage in the coronary, peripheral
arterial, cerebral, and renal arterial beds.
B A C KG ROUND Arterial stiffness is associated with adverse cardiovascular outcomes. We hypoth-
esized that aPWV is associated with subclinical measures of atherosclerosis—coronary artery calciﬁca-
tion (CAC) and ankle-brachial index (ABI) and arteriolosclerosis—brain white matter hyperintensity
(WMH) and urine albumin-creatinine ratio (UACR).
METHOD S Participants (n  812; mean age 58 years; 58% women, 71% hypertensive) belonged to
hypertensive sibships and had no history of myocardial infarction or stroke. aPWV was measured by
applanation tonometry, CAC by electron beam computed tomography, ABI using a standard protocol,
WMH volume by brain magnetic resonance, and UACR by standard methods. WMH was log-transformed,
whereas CAC and UACR were log-transformed after adding 1 to reduce skewness. The associations of
aPWV with CAC, ABI, WMH, and UACR were assessed by multivariable linear regression using generalized
estimating equations to account for the presence of sibships. Covariates included in the models were
age, sex, body mass index, history of smoking, hypertension and diabetes, total and high-density
lipoprotein cholesterol, estimated glomerular ﬁltration rate, use of aspirin and statins, and pulse
pressure.
R E S U L T S The mean  SD aPWV was 9.8  2.8 m/s. After adjustment for age, sex, conventional
cardiovascular risk factors, and pulse pressure, higher aPWV (1 m/s increase) was signiﬁcantly associated
with higher log (CAC  1) (  SE  0.14  0.04; p  0.0003), lower ABI (  SE  0.005  0.002;
p  0.02), and greater log (WMH) (  SE  0.03  0.009; p  0.002), but not with log (UACR  1)
(p  0.66).
CONC L U S I O N S Higher aPWV was independently associated with greater burden of subclinical
disease in coronary, lower extremity, and cerebral arterial beds, highlighting target organ damage as a
potential mechanism underlying the association of arterial stiffness with adverse cardiovascular
outcomes. (J Am Coll Cardiol Img 2011;4:754–61) © 2011 by the American College of Cardiology
Foundation
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755rterial stiffness increases with aging (1), and this
increase is accelerated in the presence of car-
diovascular risk factors such as hypertension
and diabetes (2). Greater arterial stiffness
has been shown to be an independent predictor of
adverse cardiovascular outcomes including mortality
(3), myocardial infarction (3), stroke (3), atrial fibril-
ation (4), cognitive decline (5), and renal dysfunction
6). Aortic pulse wave velocity (aPWV), a robust
easure of arterial stiffness, helps to discriminate
etween patients at low and high risk of adverse
ardiovascular outcomes when added to conventional
isk factors (7).
Patients with hypertension are predisposed to
rteriosclerosis (both atherosclerosis of large vessels
nd arteriolosclerosis of small vessels) and are at
ncreased risk of target organ damage and related
linical sequelae. Given its adverse effects on the
ardiovascular system, arterial stiffness may inde-
endently contribute to target organ damage in
ypertensives. Moreover, knowledge of potentially
eversible (or treatable) arterial function parameters
hat contribute to the progression of arteriosclerosis
n hypertensive individuals could aid in the devel-
pment of therapies aimed at preventing the clinical
equelae of target organ damage.
Although previous studies assessed the associa-
ions of arterial stiffness with arteriosclerosis (8–12),
ost were limited to 1 or 2 measures of target organ
amage. Furthermore, a significant proportion of
he available studies included only untreated hyper-
ensive subjects. Whether central arterial stiffness
ontributes to subclinical small- and large-vessel target
rgan damage in different arterial beds in treated
ypertensive patients remains unclear. To better un-
erstand the role of arterial stiffness in target organ
amage, we investigated whether aPWV is associated
ith noninvasive measures of subclinical large- and
mall-vessel arteriosclerosis, including coronary artery
alcification (CAC), the ankle-brachial index (ABI),
olume of white matter hyperintensity (WMH) in the
rain, and urine albumin/creatinine ratio (UACR) in
cohort enriched for hypertension.
M E T H O D S
Study sample. The study sample consisted of non-
Hispanic white participants from the GENOA
(Genetic Epidemiology Network of Arteriopathy)
study (13), and participants belonged to sibships in
which at least 2 family members received a diagno-
sis of hypertension before the age of 60 years.
Between January 2003 and December 2008, 874participants completed the study protocol. Fifty-
one participants with history of myocardial infarc-
tion or stroke and 11 participants with technically
inadequate aPWV studies were excluded, leaving
812 participants for the final analysis. For analyses
related to the ABI, we excluded 17 participants
with an ABI 1.4 because the ABI in this range is
unreliable due to poorly compressible arteries. The
project was approved by the Mayo Institutional
Review Board, and participants gave informed con-
sent. Details regarding the assessment of baseline
characteristics in the GENOA study cohort were
previously described (14). Information regarding
age, sex, hypertension, diabetes, body mass index,
history of smoking, total and high-density lipopro-
tein cholesterol, estimated glomerular filtration rate,
blood pressure, and medication use was available for
all 812 participants.
Noninvasive assessment of subclinical vascular disease.
The presence and extent of large-vessel
damage were assessed in the coronary and
peripheral arterial beds. Coronary athero-
sclerotic burden was assessed by CAC in
791 participants, which was measured
with an Imatron C-150 EBCT scanner
(Imatron Inc., South San Francisco, Cal-
ifornia), as previously described (15). A
score for each focus of CAC was deter-
mined, and the total calcium score was
obtained by summing individual foci
scores from each of the 4 anatomic sites
(left main, left anterior descending, cir-
cumflex, and right coronary arteries) (16).
The presence of coronary atherosclerosis
was defined as a CAC score 0.
Peripheral arterial atherosclerosis was assessed by
measuring the participants’ ABI, as previously de-
scribed (17). The lower of the average ABIs from
the 2 legs was used in the analyses. The presence of
lower extremity atherosclerosis was defined as an
ABI 0.9. A total of 790 participants had their
ABI measured. After excluding the 17 participants
with an ABI 1.4, 773 participants were included
in ABI analyses.
The presence and extent of small-vessel arterio-
losclerosis were assessed in the cerebral and renal
arterial beds. Brain WMH volume (cm3), a surro-
gate for subclinical cerebral arteriolosclerosis, was
obtained via cardiac magnetic resonance in 638
participants. All cardiac magnetic resonance scans
were performed on Signa 1.5-T CMR scanners
(GE Medical Systems, Waukesha, Wisconsin), as
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756processed at the Mayo Clinic, Rochester, Minne-
sota. The presence of cerebral arteriolosclerosis was
defined as WMH 5.7 cm3, the median value in
he study participants.
The UACR (milligrams of albumin/grams of
reatinine) was used as a measure of renal glomer-
lar dysfunction. The first voided urine was col-
ected on the morning of the study visit and stored
t 80°C until analyzed. Urine albumin and urine
reatinine concentrations were measured by stan-
ard methods on a Hitachi 911 Clinical Chemistry
nalyzer (Roche Diagnostics, Indianapolis, Indi-
na). The UACR was available for 760 participants.
he presence of renal arteriolosclerosis was defined
s a UACR 10 mg/g.
Aortic pulse wave velocity. Participants were asked
o fast for 12 h and withhold vasoactive medica-
ions, alcohol, and caffeine for 24 h before the study
isit. Arterial tonometry of the right carotid and
emoral arteries was performed using the Sphygmo-
or apparatus (AtCor Medical, Sydney, Australia)
ith simultaneous electrocardiographic recording,
s previously described (19). The mean  SD
ntervals (in months) between assessment of each
easurement of subclinical arteriosclerosis and sub-
equent measurement of aPWV were 28.11 
9.53 for CAC, 14.4 11.86 for ABI, 13.5 22.3
or WMH, and 28.9  19.4 for UACR.
Statistical methods. To reduce skewness, WMH was
og-transformed, and UACR and CAC were log-
ransformed after adding 1. The skewness statistics
fter transformation were 0.33 for log (CAC  1),
.04 for (WMH), and 0.99 for log (UACR  1),
hich were within the acceptable range of 2 to2.
pearman correlation coefficients between aPWV
nd log (CAC  1), ABI, log (WMH), and log
UACR  1) were calculated.
Multivariable linear regression analyses were per-
ormed to assess the associations of aPWV with
easures of large-vessel atherosclerosis, represented
y log (CAC  1) and ABI, and small-vessel
rteriolosclerosis, represented by log (WMH), and
og (UACR1). Analyses were performed for the
ntire cohort (n  812) and in the subsets of
ypertensives (n  577) and “ever” smokers (n 
75). We adjusted sequentially for: 1) age and sex
model 1); 2) age, sex, hypertension, diabetes, body
ass index, history of smoking, total and high-
ensity lipoprotein cholesterol, estimated glomeru-
ar filtration rate, and use of aspirin and statins
model 2); and 3) model 2 variables and pulse
ressure (by including systolic blood pressure [SBP]
nd diastolic blood pressure [DBP] in the model)model 3). The WMH models were also adjusted
or total brain volume. Because SBP is used in the
alculation of the ABI, to avoid colinearity, we did
ot adjust ABI models for SBP and DBP (pulse
ressure). In the multivariable models, backward
limination was performed with a criterion of p 
.05 to stay in the model. We investigated potential
nteractions between aPWV and age, sex, hyperten-
ion, and smoking, respectively, in predicting
igher CAC, WMH, UACR, and lower ABI.
We also performed multivariable logistic regres-
ion analyses, adjusting for relevant covariates as
tated previously, to assess whether aPWV was
ssociated with the presence of early target organ
amage as reflected by a CAC score 0, an ABI
0.9, WMH 5.7 cm3, and a UACR 10 mg/g.
djusted odds ratios and 95% confidence intervals
ere calculated to assess the odds of having sub-
linical target organ damage for each 1 m/s increase
n aPWV.
Because our cohort consisted of sibships, we used
eneralized estimating equations to account for the
ossible impact of familial correlations. A p value
0.05 was considered to be statistically significant.
tatistical analyses were performed with SAS ver-
ion 8.2 (SAS Institute, Cary, North Carolina).
R E S U L T S
The baseline characteristics of the study partici-
pants are outlined in Table 1. The mean age of
participants was 58.4 years, and 57.6% were
women. Hypertension was present in 71.1% of
participants, and 11.2% had diabetes. The mean 
D aPWV was 9.8  2.8 m/s.
Scatterplots depicting the correlations of aPWV
with log (CAC 1) (n 791), ABI (n 773), log
(WMH) (n  638), and log (UACR  1) (n 
760) are shown in Figure 1. aPWV correlated
positively with log (CAC  1), and log (WMH),
log (UACR  1) and inversely with ABI.
After adjustment for age and sex, a higher aPWV
was associated with a greater amount of CAC,
greater WMH volume, and a lower ABI. These
associations remained statistically significant after
further adjustment for confounders (Table 2). A
statistically significant association of aPWV with
CAC and WMH was present even after additional
adjustment for pulse pressure (Table 2). After
adjustment for age and sex, no statistically signifi-
cant association was observed between aPWV and
UACR (Table 2). We found significant interactions
between greater aPWV and older age in the pre-
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757diction of the ABI (p  0.002) and WMH (p 
.0007) and between greater aPWV and smoking in
he prediction of WMH (p  0.0009), suggesting
hat aPWV was more strongly associated with these
henotypes in older individuals and those with a
istory of smoking. We did not find a significant
nteraction between greater aPWV and the pres-
nce of hypertension in the prediction of the 4
henotypes. Thus, results were similar in the sub-
roup of hypertensives: in fully adjusted multivari-
ble models, greater aPWV was independently
ssociated with greater log (CAC  1) (n  556,
  SE  0.15  0.04, p  0.0002); lower ABI
(n  773,   SE  0.005  0.002, p  0.03 );
nd higher log (WMH) (n 457,  SE 0.03
0.01, p 0.005) but not with greater log (UACR 1)
(n  543, p  0.35 after age and sex adjustment).
Among smokers, aPWV was significantly associ-
ated with log (CAC 1) only (n 366,  SE
.14  0.04, p  0.001) after adjustment for the
Table 1. Baseline Characteristics of the Study Participants (n 
M
Age, yrs
Men
Body mass index, kg/m2
Waist circumference, cm
Hypertension
Systolic blood pressure, mm Hg
Diastolic blood pressure, mm Hg
Total cholesterol, mg/dl
HDL cholesterol, mg/dl
Statin use
Antihypertensive use
ACE inhibitor/ARB use
Calcium channel blocker use
Beta-blocker use
Diuretic use
Aspirin use
Diabetes
Smoking (past or current)
Estimated glomerular ﬁltration rate, ml/min/1.73 m2
Coronary artery calciﬁcation score (n  791)
Ankle-brachial index (n  773)
White matter hyperintensity volume, cm3 (n  638)
Urine albumin-creatinine ratio, mg/g (n  760)
Aortic pulse wave velocity, m/s
Coronary artery calciﬁcation present
Ankle-brachial index 0.9
White matter hyperintensity volume 5.7 cm3
Urine albumin/creatinine ratio 10, mg/g
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker
lipoprotein.same variables as in model 3.In the logistic regression analyses for predicting
the presence of target organ damage, a 1 m/s
increase in aPWV was independently associated
with a higher odds of having a CAC score 0 and
an ABI 0.9 , but not WMH volume 5.7 cm3 or
UACR 10 mg/g (Table 3).
D I S C U S S I O N
In a cohort consisting primarily of treated hyper-
tensive participants, aPWV, a well-established
measure of central arterial stiffness, was indepen-
dently associated with the extent of subclinical
target organ damage in coronary, cerebral, and
peripheral arterial beds, but not renal arterial beds.
Further, aPWV also independently predicted the
presence of coronary and lower extremity athero-
sclerosis. To the best of our knowledge, this is the
first study reporting the simultaneous associations
of aPWV with subclinical coronary, lower extrem-
Unless Otherwise Speciﬁed)
n/No.  SD, % Median (IQR)
.4 9.7 59.09 (51.10–65.33)
42.4
.3 5.8 29.60 (26.33–33.35)
.6 156.0 99.3 (89.2–109.2)
71.1%
.9 16.3 129.00 (119.00–142.00)
.6 8.7 75.0 (69.0–80.0)
.9 33.1 196.8 (127.0–394.5)
.7 15.5% 50.0 (24.9–115.3)
26.72%
67.2%
32.2%
12.8%
31.5%
35.8%
39.3%
11.21%
46.18%
.0 13.3 65.2 (26.4–113.9)
.9 484.1 12.04 (0–144.60)
.15 0.12 1.15 (1.01–1.23)
.5 6.2 5.7 (4.3–7.9)
.2 48.5 3.1 (0–1177.8)
.8 2.8 9.1 (7.90–10.98)
60.6%
3.3%
50%
10.1%
L  high-density lipoprotein; IQR  interquartile range; LDL  low-density812
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758consisting predominantly of treated hypertensive
adults.
Arterial stiffness increases with increased SBP.
However, in our study, the associations of aPWV
with CAC and WMH remained despite adjust-
ment for SBP. Further adjustment for DBP did
not alter the association, suggesting that the
effects of arterial stiffness on the coronary and
cerebral vasculatures are independent of pulse
pressure, a readily obtained but crude marker of
arterial stiffness. Thus, aPWV appears to be a
better predictor of the extent of subclinical target
organ damage, providing information beyond
what would be obtained by measuring brachial
pulse pressure alone.
Measures of arterial stiffness predict adverse car-
diovascular events in different populations. In the
Framingham Heart Study offspring cohort (20),
Figure 1. Correlations of aPWV With Coronary, Lower Extremity
Scatterplot depicting the unadjusted correlations of aortic pulse wa
(UACR  1). ABI  ankle-brachial index; CAC  coronary artery calc
matter hyperintensity volume.
Linear Regression Analysis Assessing the Association of aPWV (
(CAC  1) (n  791) ABI (n  773)
SE p Value   SE p Value
 0.04 0.0001 0.005 0.002 0.01
 0.04 0.0002 0.005 0.002 0.007
 0.04 0.0003  
adjusted for total brain volume. †Adjusted for age and sex. ‡Adjusted for mo
otal cholesterol, high-density lipoprotein cholesterol, and use of statins and aspir
t was not done for the ABI given the issue of colinearity because systolic blood
x; aPWV  aortic pulse wave velocity; CAC  coronary artery calciﬁcation; UACR  uaPWV was independently associated with cardio-
vascular events. Similarly, Terai et al. (21) demon-
strated that aPWV predicted myocardial infarction
or stroke in a cohort of 676 patients with essential
hypertension during a mean follow-up of 57
months. A recent meta-analysis including indi-
viduals at high and low risk of cardiovascular
events (3) corroborated such findings, showing
that aPWV was not only significantly associated
with an increased risk of adverse cardiovascular
events and mortality, but also with all-cause
mortality. Associations of aPWV with various
markers of subclinical target organ damage have
been previously reported (11); however, the study
included a small number of patients (n  178),
nd, differently from our study, consisted solely
f untreated hypertensive individuals. Our work
uggests a possible mechanism linking aPWV to
rebral, and Renal Arteriosclerosis
elocity (aPWV) with log (CAC  1), ABI, log (WMH), and log
tion; UACR  urine albumin/creatinine ratio; WMH  brain white
/s Increase) With CAC, ABI, Brain WMH Volume, and UACR
Log (WMH)* (n  638) Log (UACR  1) (n  760)
  SE p Value   SE p Value
.02 0.009 0.007 0.02 0.02 0.28
.03 0.009 0.004 0.007 0.02 0.96
.03 0.009 0.002 0.007 0.02 0.66
variables plus hypertension, diabetes, body mass index, smoking, estimated
djusted for model 2 variables plus systolic and diastolic blood pressure (pulse
ure is used to calculate the ABI., Ce
ve v
iﬁcaTable 2. Multivariable 1 m
Log
 
Model 1† 0.19 0
Model 2‡ 0.14 0
Model 3§ 0.14 0
*Log (WMH) models were del 1
glomerular ﬁltration rate, t in. §A
pressure). This adjustmen pressrine albumin-creatinine ratio; WMH  brain white matter hyperintensity.
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759adverse cardiovascular outcomes via its associa-
tion with subclinical vascular disease.
The results of our study indicate that aPWV is
independently associated with the presence and
extent of CAC, and this association was also pres-
ent in the subsets of hypertensives and smokers. We
previously showed that aPWV is independently
associated with CAC in a community-based cohort
(19), whereas the association of arterial stiffness
with CAC has also been explored in different
cohorts including the elderly (22), postmenopausal
women (23), and patients with diabetes (24) and
renal disease (25), confirming a positive association.
The present report is the first to demonstrate an
independent association of aPWV with CAC in a
cohort consisting mainly of treated hypertensive
individuals without a history of myocardial infarc-
tion or stroke. The association of aPWV with the
ABI, a measure of atherosclerosis in the legs, also
confirms that arterial stiffness is related to large-
vessel atherosclerotic burden. Only 2 previous stud-
ies assessed the association of arterial stiffness with
the ABI, also demonstrating an inverse association
(26,27). However, such studies used brachial-ankle
pulse wave velocity, which measures elements of
both central and peripheral arterial stiffness rather
than aPWV. A possible mechanism leading to the
associations of aPWV with coronary and lower
extremity subclinical atherosclerosis is that common
risk factors (such as age, diabetes, and hypertension)
promote both atherogenesis and increased arterial
stiffness. Further, inflammation underlies both ar-
terial stiffness (28) and atherosclerosis (29). Addi-
tionally, the presence of atherosclerotic plaque itself
could lead to increased arterial stiffness (30).
In our study, aPWV was an independent predic-
tor of higher WMH volume in the entire cohort
and also in the subgroup of hypertensive partici-
pants. aPWV was more strongly associated with
WMH in older individuals and those with a history
of smoking. The association of arterial stiffness and
Table 3. Logistic Regression Analyses Showing the Odds of Sub
CAC Score >0 AB
OR 95% CI p Value OR 95%
Model 1† 1.23 1.12–1.36 0.0001 1.18 1.05–
Model 2‡ 1.17 1.06–1.29 0.002 1.17 1.04–
Model 3§ 1.18 1.07–1.31 0.001 
Sample sizes are the same as in Table 2. *Log (WMH) models were adjusted for t
mass index, smoking, estimated glomerular ﬁltration rate, total cholesterol, high
diastolic blood pressure (pulse pressure). This adjustment was not done for th
CI  conﬁdence interval; OR  odds ratio; other abbreviations as in Table 2.subclinical cerebral arteriolosclerosis is controver-sial, and results have varied depending on the
population studied. aPWV has been shown to be
associated with brain WMH in the elderly (31) and
also in hypertensive individuals (12), whereas no
association was found in a cohort of young, pre-
dominantly normotensive patients (32). Further-
more, WMH appears to correlate with cerebral
small-vessel disease and a decline in cognitive func-
tion (33). aPWV has also been associated with
progressive cognitive dysfunction in elderly individ-
uals (1), suggesting that arterial stiffness may influ-
ence the onset of vascular dementia. By decreasing
the impedance mismatch between central and pe-
ripheral arteries and decreasing the amount of wave
reflection, aortic stiffness may impair the pressure-
buffering abilities of the arteries and arterioles,
resulting in the delivery of a highly pulsatile pres-
sure and augmented flow into the brain microcir-
culation (34), rendering it more susceptible to
vascular damage.
A similar mechanism could be responsible for
small-vessel damage in the kidneys due to highly
pulsatile pressures associated with aortic stiffness,
leading to albuminuria. Although an association
between arterial stiffness and microalbuminuria was
previously reported (8,11,35,36), we were unable to
confirm this in our study. Because a reduction in
aPWV resulting from antihypertensive treatment
has been shown to decrease the UACR (37), the
lack of association may be because the participants
in our study had a low UACR (mean  8.2 mg/g,
normal 30 mg/g), their blood pressure was, in
general, well controlled, and nearly a third of
participants were being treated with either
angiotensin-converting enzyme inhibitors or angio-
tensin receptor blockers, drugs known to decrease
microalbuminuria. Moreover, most participants did
not have significant renal dysfunction (mean esti-
mated glomerular filtration rate 65.4 ml/min/1.73 m2).
Differently from our study, an association between
the UACR and arterial stiffness was reported in
ical Target Organ Damage for Each 1 m/s Increase in aPWV
.9 WMH >5.7 cm3* UAC
p Value OR 95% CI p Value OR 9
0.008 1.03 0.94–1.12 0.57 1.06 0
0.009 1.02 0.94–1.12 0.59 1.03 0
 1.04 0.95–1.14 0.42 1.00 0
brain volume. †Adjusted for age and sex. ‡Adjusted for model 1 variables plus hyp
sity lipoprotein cholesterol, and use of statins and aspirin. §Adjusted for model 2
I to avoid colinearity because systolic blood pressure is used to calculate the ABclin
I <0 R >10 mg/g
CI 5% CI p Value
1.33 .96–1.17 0.19
1.32 .94–1.13 0.51
.91–1.11 0.92
otal ertension, diabetes, body
-den variables plus systolic and
e AB I.previous studies that included mainly diabetic pa-
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760tients (38) or untreated hypertensive patients
(8,11,36).
aPWV can be relatively easily measured by arte-
rial tonometry and used in the office setting, high-
lighting the potential clinical advantages of using
aPWV in the assessment and risk stratification of
hypertensive patients. Furthermore, measurement
of aPWV may aid in better risk stratification of
asymptomatic individuals, and therapies aimed at
arterial de-stiffening may be used in the hope of
preventing onset and/or progression of vascular
disease before the development of clinically mani-
fest target organ damage. Arterial de-stiffening can
result from weight loss (39), aerobic exercise (39),
low-fat, low-sodium diets (40), statins (41), and
antihypertensive agents (42).
Study limitations. The main strengths of our study
re the use of several objective measures of vascular
isease in a relatively large cohort, and our ability to
ssess the association of aPWV with subclinical
arge- and small-vessel target organ damage. How-
ver, the cross-sectional nature of the present study
oes not allow us to disentangle the temporal
ssociation between aPWV and the development of
oronary, peripheral arterial, and cerebral target
rgan damage. Our study population consisted of
on-Hispanic white, older, and mostly hypertensive
articipants. Further studies including other eth-
icities, as well as studies including younger, nor-
otensive individuals are necessary to assess
hether the effects of arterial stiffness on subclinical
ascular disease are race, age, and hypertensionNajjar SS, Scuteri A, Zonderman AB. Increased ambulatoge and aPWV in our study was not contempora-
eous; however, this should bias the results against
ny association. Despite being considered a robust
easure of arterial stiffness, a limitation of the
PWV technique is that it does not fully assess the
ressure-buffering properties of the ascending aorta
nd aortic arch.
C O N C L U S I O N S
Central arterial stiffness, assessed by aPWV, was
independently associated with objective measures of
the extent of subclinical coronary and peripheral
arterial and cerebral target organ damage as well as
the presence of subclinical coronary and lower
extremity arterial disease. Our findings suggest that
target organ damage may represent a mechanism
underlying the association of arterial stiffness and
adverse cardiovascular events. Further prospective
studies are needed to assess the temporality of the
associations between arterial stiffness and target
organ damage. Similarly, randomized clinical trials
using pharmacological and nonpharmacological ar-
terial de-stiffening therapies will be helpful in es-
tablishing whether improvement of arterial stiffness
could prevent or slow the progression of target
organ damage in hypertensive patients.
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